Tornier Announces 2012 Fourth Quarter and Full Year Conference Call
AMSTERDAM--(BUSINESS WIRE)--
Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on
providing surgical solutions to orthopaedic extremity specialists,
announced today that it will report financial results for the fourth
quarter and full year ended December 31, 2012 after the market close on
Thursday, February 21, 2013.
The Company also announced that it will host an investor conference call
to discuss the results on the same day at 4:30 PM Eastern Time.
Tornier invites all interested parties to join the call by dialing (877)
673-5355 for domestic participants and (760) 666-3805 for international
participants. The call will also be broadcast live over the Internet and
can be accessed on the Investors Relations section of the Company’s
website at www.tornier.com.
A telephone replay will be available for two weeks following the call by
dialing (855) 859-2056 for domestic participants and (404) 537-3406 for
international participants. When prompted, please enter the replay pin
number 92470331. For those who are not available to listen to the live
webcast, the call will be archived for one year on Tornier’s website.
About Tornier
Tornier is a global medical device company focused on serving
extremities specialists who treat orthopaedic conditions of the
shoulder, elbow, wrist, hand, ankle and foot. The Company's broad
offering of over 90 product lines includes joint replacement, trauma,
sports medicine, and biologic products to treat the extremities, as well
as joint replacement products for the hip and knee in certain
international markets. Since its founding approximately 70 years ago,
Tornier's "Specialists Serving Specialists" philosophy has fostered a
tradition of innovation, intense focus on surgeon education, and
commitment to advancement of orthopaedic technology stemming from its
close collaboration with orthopaedic surgeons and thought leaders
throughout the world. For more information regarding Tornier, visit www.tornier.com.
Press Release $TRNX Tornier N.V.
AMSTERDAM--(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2012 after the market close on Thursday, February 21, 2013.
The Company also announced that it will host an investor conference call to discuss the results on the same day at 4:30 PM Eastern Time.
Tornier invites all interested parties to join the call by dialing (877) 673-5355 for domestic participants and (760) 666-3805 for international participants. The call will also be broadcast live over the Internet and can be accessed on the Investors Relations section of the Company’s website at www.tornier.com.
A telephone replay will be available for two weeks following the call by dialing (855) 859-2056 for domestic participants and (404) 537-3406 for international participants. When prompted, please enter the replay pin number 92470331. For those who are not available to listen to the live webcast, the call will be archived for one year on Tornier’s website.
About Tornier
Tornier is a global medical device company focused on serving extremities specialists who treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The Company's broad offering of over 90 product lines includes joint replacement, trauma, sports medicine, and biologic products to treat the extremities, as well as joint replacement products for the hip and knee in certain international markets. Since its founding approximately 70 years ago, Tornier's "Specialists Serving Specialists" philosophy has fostered a tradition of innovation, intense focus on surgeon education, and commitment to advancement of orthopaedic technology stemming from its close collaboration with orthopaedic surgeons and thought leaders throughout the world. For more information regarding Tornier, visit www.tornier.com.
Tornier N.V.
Shawn McCormick
Chief Financial Officer
(952) 426-7646
shawn.mccormick@tornier.com
Source: Tornier N.V.